ARGAN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.94 USD | -0.57% |
|
-0.87% | +40.93% |
| May. 13 | Argan: upgrade to 'Stable' by S&P Global Ratings | CF |
| May. 02 | Argan: Mr. Le Lan and Kerlan below 30% of share capital & voting rights | CF |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's profit outlook over the next few years is a strong asset.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Construction & Engineering
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +40.93% | 880M | C | ||
| +1.19% | 71.36B | C+ | ||
| -1.78% | 56.93B | C+ | ||
| +22.52% | 38.71B | B+ | ||
| +21.83% | 33.77B | B | ||
| +12.11% | 29.48B | A- | ||
| +20.42% | 21.93B | B- | ||
| +11.86% | 19.04B | A | ||
| +39.66% | 17.99B | B+ | ||
| +75.63% | 17.78B | B |
Investor Rating
Trading Rating
-
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AGX Stock
- Ratings Argan, Inc.
